This episode covers one of the most sought after and critical fields of pharmaceutical research, cell and gene therapy. Our guest, the CEO and сo-founder of NKILT Therapeutics, Raphaël Ognar, describes a cutting-edge cell therapy biotech that is developing a novel approach to directly targeting leukemia.
